Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

No dice: Court tells AbbVie it can't force Takeda to supply a drug that's in shortage worldwide
Fierce Pharma
Thu, 09/9/21 - 11:09 am
Tags:
AbbVie, Takeda, Lupron, drug shortages, legal
AbbVie's stock and next megablockbuster take hits following new JAK warnings from FDA
Endpoints
Wed, 09/1/21 - 11:16 pm
Tags:
AbbVie, Pfizer, Rinvoq, JAK inhibitors, FDA
AbbVie’s Rinvoq is first JAK drug cleared in EU for atopic dermatitis
Pharmaforum
Wed, 08/25/21 - 09:19 pm
Tags:
AbbVie, Rinvoq, Europe, atopic dermatitis, FDA
Court upholds AbbVie's patents on blockbuster cancer drug Imbruvica, generics unlikely until 2032
Endpoints
Fri, 08/20/21 - 12:33 pm
Tags:
AbbVie, Imbruvica, patents, legal, generics
Visus, with one drug chasing AbbVie, inks deals to grow pipeline
Fierce Biotech
Thu, 08/19/21 - 10:45 am
Tags:
Visus Therapeutics, AbbVie, R&D, glaucoma, eye health
As AbbVie and Soliton shake hands on a $550M merger, the FTC says 'not so fast'
Endpoints
Wed, 08/11/21 - 12:14 pm
Tags:
AbbVie, Soliton, Resonic, M&A, FTC
Visus raises $20M ahead of data drop on rival to AbbVie prospect
Fierce Biotech
Tue, 08/10/21 - 10:28 am
Tags:
Visus Therapeutics, AbbVie, Eyenovia, funding, presbyopia
AbbVie hands back headline drug in $63B Allergan buyout to Molecular Partners after FDA rejection. What's next?
Endpoints
Mon, 08/9/21 - 11:54 pm
Tags:
AbbVie, Allergan, Molecular Partners
AbbVie, on a Mission, picks Alzheimer's, Parkinson's targets, as partner nabs $20M
Fierce Biotech
Mon, 08/9/21 - 11:05 am
Tags:
AbbVie, Mission Therapeutics, Parkinson's Disease, Alzheimer's disease
Takeda still on the hook for €398M tax linked to distant AbbVie-Shire breakup fee
Fierce Pharma
Mon, 08/2/21 - 09:40 pm
Tags:
Takeda, AbbVie, Shire, taxes, M&A
FTC drops AbbVie antitrust case, but fires a parting shot at the firm
Pharmaforum
Mon, 08/2/21 - 10:52 am
Tags:
AbbVie, FTC, Androgel, competition
AbbVie's post-Humira stalwarts Skyrizi, Rinvoq performing exactly as hoped, CEO says
Fierce Pharma
Sat, 07/31/21 - 10:07 pm
Tags:
AbbVie, earnings, Humira, Skyrizi, Rinvoq
How AbbVie Could Make an Entry Into This Rapidly Growing Drug Market
Motley Fool
Thu, 07/29/21 - 11:12 am
Tags:
AbbVie, Roche, Venclexta, MDS, breakthrough therapy
AbbVie hits go on $1B re-upped Calico deal as the Google life science spin-out continues I-O, neuro push
Fierce Biotech
Tue, 07/27/21 - 04:34 pm
Tags:
AbbVie, Calico, Google, Alphabet
FDA Greenlights AbbVie’s Antibiotic Dalvance for Acute Skin Infections in Children
BioSpace
Sat, 07/24/21 - 06:36 pm
Tags:
FDA, AbbVie, Dalvance, skin infections, pediatric, MRSA
3 Biotechs That Could Make Big Acquisitions This Year
Motley Fool
Thu, 07/22/21 - 11:10 am
Tags:
M&A, AbbVie, Vertex Pharmaceuticals, Gilead Sciences
AbbVie, Roche top data transparency list, but more could be done to build trust in medical system: report
Fierce Biotech
Wed, 07/21/21 - 10:56 am
Tags:
clinical trials, clinical trial transparency, AbbVie, Roche
AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA
Yahoo/Benzinga
Sun, 07/18/21 - 09:45 pm
Tags:
AbbVie, Eli Lilly, atopic dermatitis, FDA, Rinvoq, olumiant
AbbVie-backed Stemson snags $15M series A for hairy brush-up with Rogaine, Propecia
Fierce Biotech
Fri, 07/16/21 - 11:00 am
Tags:
AbbVie, Stemson, funding, hair loss
Novartis may have the most new drug approvals, but Roche, Lilly and AbbVie's launches win on value: report
Fierce Pharma
Thu, 07/15/21 - 12:39 pm
Tags:
Novartis, AbbVie, GSK, Roche, Eli Lilly, AstraZeneca, FDA, drug launches, drug approvals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.